ACURX PHARMACEUTICALS INCORPORATED (ACXP)
Track the next or latest earnings date for ACURX PHARMACEUTICALS INCORPORATED, review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
finance.yahoo.com · 2026-07-31T13:45:23
SpaceX stock whipsawed through a volatile week, swinging from an all-time low to a sharp rebound and closing at a new low, as investors braced for the newly public company's first earnings report and a major share unlock.
Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Up 2.2% – Here’s What Happened - Markets Dailythemarketsdaily.com · 2026-07-31T05:01:24
One investment analyst has rated ... stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $31.00. ... The company has a market cap of $6.11 million, a price-to-earnings ratio of -0.35 and a beta of -2.05. The firm has a fifty day mo…
Earnings call transcript: AXT tops Q2 2026 estimates, shares jump after hours By Investing.cominvesting.com · 2026-07-30T21:38:00
Earnings call transcript: AXT tops Q2 2026 estimates, shares jump after hours
AXT set to report earnings as profitability milestone looms By Investing.comca.investing.com · 2026-07-30T17:52:10
AXT set to report earnings as profitability milestone looms
American Express (NYSE:AXP) Growth Story Keeps Buildingkalkinemedia.com · 2026-07-30T15:15:00
American Express strengthened revenue expectations through resilient customer spending, premium financial services, digital innovation, and disciplined long-term business execution.
Upcoming earnings date
Pre-market
Fiscal quarter: 2026-06-30
EPS estimate: -$0.42
Revenue estimate: N/A
Market cap: $6.10M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Aug 14, 2026 | 2026-06-30 | Pre-market | -$0.42 | N/A |